1.0
26. März 2018
Mitarbeiter (anonym)
Ehemaliger Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Great and unique product. No real competitor to bedside portable blood analyser.
Kontras
Plagued with quality issues due to management bad decision: the CRD blue cartridge continues to have yield and other quality issues. Very weak Regulatory Affairs department (management promoted over their competencies). Leading by fear. Worse benefits packages compared to the rest of Abbott. Hourly folks are paid below industry levels. High pressure environment.